The patentatibility of medicinal inventions related to personalized medicine in Japan

Article Abstract:

The Japan Patent Office in April 2005 clarified its Examination Guidelines for inventions related to the use of medicines, which, until then, were not considered patentable in Japan. The new guidelines, which give enhanced patent protection to these inventions, are expected to have a great impact on pharmaceutical companies and have an effect on their research strategies.

Japan, Japan. Patent Office

---

Emerging patent issues in genomic diagnostics

Article Abstract:

The US Supreme Court is interested in reconstructing patent law in a way that may affect the genomic diagnostics industry. Diagnostic patents raise important difficulties in the future for pharmacogenetics and of tests and devices that could identify many mutations quickly.

Medical testing products, Pharmacogenetics, Pharmacogenomics

---

Reach-through claims for drug target patents: Rx for pharmaceutical policy

Article Abstract:

Reach-through claims to drug targets is an issue of concern for pharmaceutical patent law. A few cases that involve such reach-through claims are illustrated.

Product standards, safety, & recalls, Standards, Analysis, Powers and duties, United States. Food and Drug Administration, Drug approval

Similar abstracts:

• Abstracts: The patentability of human embryonic stem cells in Europe. FDA likely to further restrict erythropoietin use for cancer patients
• Abstracts: The withering of criticism: A review of professional, Foucauldian, ethnographic, and epistemic studies in accounting
• Abstracts: The business of making vaccines. Next generation flu vaccine boosted by Chiron debacle

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.